|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/68 | (2017.01) |
| A61P 35/00 | (2018.01) | ||
| A61K 47/65 | (2017.01) | ||
| A61K 9/19 | (2013.01) | ||
| A61K 9/19 | (2006.01) | ||
| A61K 9/08 | (2013.01) | ||
| A61K 47/20 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 9/08 | (2006.01) | ||
| A61K 38/00 | (2013.01) | ||
| A61K 38/00 | (2006.01) | ||
| C07K 16/32 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 39/39591 | (2013.01) | ||
| A61K 47/20 | (2006.01) | ||
| C07K2317/24 | (2013.01) | ||
| C07K2317/94 | (2013.01) | ||
| C07K2317/92 | (2013.01) | ||
| A61K 47/6803 | (2017.08) | ||
| A61K 47/6849 | (2017.08) | ||
| A61K 47/6889 | (2017.08) | ||
| A61K 47/6851 | (2017.08) |
| (11) | Patento numeris | 3811979 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20776430.9 |
| Europos patento paraiškos padavimo data | 2020-03-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-04-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-11-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2020/081138 |
| Data | 2020-03-25 |
| (87) | Numeris | WO 2020/192693 |
| Data | 2020-10-01 |
| (30) | Numeris | Data | Šalis |
| 201910231203 | 2019-03-26 | CN |
| (72) |
LI, Zhuanglin , CN
XU, Qiaoyu , CN
YAO, Xuejing , CN
BAO, Qianjing , CN
FANG, Jianmin , CN
|
| (73) |
RemeGen Co., Ltd. ,
China (Shandong) Pilot Free Trade Zone
Yantai District, Yantai Development Zone
No.58 Beijing Middle Road, Shandong 264006,
CN
|
| (54) | ANTI-HER2 ANTIBODY DRUG CONJUGATE PHARMACEUTICAL PREPARATION |
| ANTI-HER2 ANTIBODY DRUG CONJUGATE PHARMACEUTICAL PREPARATION |